LHC Group, Inc. (LHCG)

4 members of Congress have disclosed 21 trades in LHC Group, Inc. (LHCG) via STOCK Act filings. The most recent disclosure was a sale by Josh Gottheimer on 21 June 2022. The most active traders have been John A. Yarmuth (9), Josh Gottheimer (5), and Sara Jacobs (4). Aggregate disclosed activity totals roughly $97K in purchases and $2.2M in sales (midpoint estimates from bracketed disclosure amounts).

Want to automatically copy Pelosi trades?

Mirror Nancy Pelosi's portfolio with just one click on eToro.

Copy Trading does not amount to investment advice. The value of your investments may go up or down. Your capital is at risk.

Past Performance is not an indication of future results.

Price data is not available for LHCG
This ticker may have been delisted, renamed, or is not publicly quoted, so no live price, statistics or chart can be shown. The congressional trades disclosed for it are listed below.

Congressional Trading Activity for LHCG

5 transactions
Compliance: 71%
Josh Gottheimer21 Jun 202222 Jul 2022SaleStock$1,001 - $15,000N/A
Josh Gottheimer4 Nov 202113 Dec 2021PurchaseStock$1,001 - $15,000N/A
Sara Jacobs9 Apr 202128 May 2021SaleStock$50,001 - $100,000N/A
Sara Jacobs9 Apr 202121 Jul 2022SaleStock$50,001 - $100,000N/A
Sara Jacobs19 Feb 202121 Jul 2022PurchaseStock$15,001 - $50,000N/A

See every trade

Sign in free to see the full trade history for this stock.

Stock Overview

Market Data

Market Cap

$5.29B

Volume

1.28M

Beta

0.42

P/E Ratio

82.83

Fundamentals

EPS

$2.05

Div. Yield

-

Open

$169.16

Day Range

$169.16 – $169.82

Company Information

Sector
Healthcare
Industry
Medical - Care Facilities
Exchange
NASDAQ · USD
Country
US
CEO
Keith G. Myers
IPO Date
2005-06-09

LHC Group, Inc. is a healthcare organization delivering a comprehensive array of post-acute care services, predominantly serving Medicare recipients across the United States. Its operations are organized into five distinct divisions: Home Health, Hos...

Earnings

Recent Quarters

Q3 202231 Dec
EPS$-0.06
Q3 20222 Nov
EPS$1.06
Miss 19.7%
Q2 20223 Aug
EPS$0.98
Miss 27.4%
Q4 202123 Feb
EPS$1.26
Miss 4.5%
Q3 202131 Dec
EPS$0.69
Q3 20213 Nov
EPS$1.45
Miss 4.0%
Q2 20214 Aug
EPS$1.62
Beat 4.5%
Q1 20215 May
EPS$1.39
Beat 11.2%
Q4 202025 Feb
EPS$1.40
Beat 0.7%
Q3 20205 Nov
EPS$1.63
Beat 19.0%
Q2 20205 Aug
EPS$1.23
Beat 55.7%
Q1 20207 May
EPS$0.75
Beat 8.7%
Q4 201926 Feb
EPS$1.15
Beat 0.9%
Q3 20196 Nov
EPS$1.26
Beat 16.7%
Q2 20197 Aug
EPS$1.07
Beat 5.9%
Q1 20198 May
EPS$0.98
Beat 10.1%
Q4 201827 Feb
EPS$1.03
Beat 1.0%
Q3 201831 Oct
EPS$0.95
Beat 0.0%
Q2 20181 Aug
EPS$0.84
Beat 7.7%
Q1 20182 May
EPS$0.63
Beat 5.0%
Q4 201728 Feb
EPS$0.62
Beat 1.6%
Q3 20176 Nov
EPS$0.64
Beat 8.5%
Q2 20172 Aug
EPS$0.63
Beat 16.7%
Q1 20173 May
EPS$0.53
Beat 20.4%
Q4 20168 Mar
EPS$0.57
Beat 0.0%
Q3 20162 Nov
EPS$0.55
Beat 10.0%
Q2 20163 Aug
EPS$0.52
Beat 0.0%
Q1 20164 May
EPS$0.44
Beat 18.9%
Q4 20152 Mar
EPS$0.53
Beat 17.8%
Q3 20154 Nov
EPS$0.50
Beat 16.3%
Q2 20155 Aug
EPS$0.51
Beat 24.4%
Q1 20156 May
EPS$0.39
Beat 11.4%
Q4 201425 Feb
EPS$0.45
Beat 32.4%
Q3 20145 Nov
EPS$0.36
Beat 5.9%
Q2 20146 Aug
EPS$0.35
Beat 9.4%
Q1 20147 May
EPS$0.24
Miss 11.1%
Q4 20135 Mar
EPS$0.29
Miss 9.4%
Q3 20136 Nov
EPS$0.31
Beat 3.3%
Q2 20137 Aug
EPS$0.34
Beat 21.4%
Q1 20138 May
EPS$0.37
Beat 12.1%
Q4 20126 Mar
EPS$0.43
Beat 16.2%
Q3 20127 Nov
EPS$0.38
Beat 2.7%
Q2 20126 Aug
EPS$0.32
Miss 20.0%
Q1 20122 May
EPS$0.44
Beat 18.9%
Q4 201129 Feb
EPS$0.39
Beat 11.4%
Q3 20112 Nov
EPS$0.39
Miss 22.0%
Q2 20113 Aug
EPS$0.56
Beat 14.3%
Q1 20114 May
EPS$0.42
Beat 16.7%
Q4 20102 Mar
EPS$0.63
Miss 4.5%
Q3 20101 Nov
EPS$0.73
Beat 4.3%
Q2 20104 Aug
EPS$0.68
Miss 2.9%
Q1 201028 Apr
EPS$0.64
Beat 0.0%
Q4 20093 Mar
EPS$0.70
Beat 37.3%
Q3 200928 Oct
EPS$0.54
Beat 3.9%
Q2 20094 Aug
EPS$0.57
Beat 7.5%
Q1 20096 May
EPS$0.62
Beat 29.2%
Q4 200810 Mar
EPS$0.60
Beat 33.3%
Q3 200829 Oct
EPS$0.45
Beat 21.6%
Q2 200830 Jul
EPS$0.35
Beat 12.9%
Q1 200830 Apr
EPS$0.31
Beat 6.9%
Q4 200727 Feb
EPS$0.39
Beat 5.4%
Q3 200731 Oct
EPS$0.38
Beat 11.8%
Q2 20071 Aug
EPS$0.35
Miss 2.8%
Q1 200730 Apr
EPS$0.35
Beat 2.9%
Q4 200628 Feb
EPS$0.33
Beat 13.8%
Q3 20062 Nov
EPS$0.29
Beat 11.5%
Q2 20068 Aug
EPS$0.26
Beat 8.3%
Q1 20069 May
EPS$0.23
Beat 9.5%
Q4 200523 Feb
EPS$0.19
Beat 11.8%
Q3 20058 Nov
EPS$0.17
Miss 5.6%
Q2 20059 Aug
EPS$0.20
Beat 0.0%

9 politicians traded within 30 days

No dividend data available for this stock.

No stock split data available for this stock.

Similar Stocks

Based on congressional trading patterns

Smart Recommendations
No similar stocks found
No congressional trading patterns available for recommendations

Frequently Asked Questions about LHCG

Which members of Congress have traded LHCG?
4 members of Congress have disclosed 21 trades in LHC Group, Inc. (LHCG) under the STOCK Act. The most active traders are John A. Yarmuth, Josh Gottheimer, and Sara Jacobs.
When was LHCG most recently disclosed by Congress?
The most recent LHCG disclosure was a sale by Josh Gottheimer on 21 June 2022.
What is the total disclosed congressional trading volume for LHCG?
Members of Congress have disclosed approximately $97K in LHCG purchases and $2.2M in sales. These figures are midpoint estimates derived from the bracketed amount ranges used in STOCK Act filings.
How can I track new congressional trades in LHCG?
This LHCG page updates as soon as new STOCK Act disclosures are filed for LHC Group, Inc.. Every trade, politician, transaction date and amount range is surfaced above, typically within hours of the official filing appearing on the House or Senate disclosure portals.
Pelosi Tracker
© 2026 - All rights reserved. Powered by Vantara Labs
Pelosi Tracker is an independent, third-party platform. It is not affiliated with, endorsed by, or in any way associated with Nancy Pelosi, her office or her representatives, or with any other member of Congress. Any use of her name is solely for the purpose of discussing publicly available information.The information provided by Pelosi Tracker is for informational and educational purposes only and is not intended to serve as, nor should it be construed as, financial or investment advice. The data presented here is sourced from publicly available filings and records. While we strive for accuracy, timeliness, and completeness, we do not guarantee that all information is error-free or current.